Prof. Mohamed Ahmed Al-Kanhal,  Acting Executive President of the (SFDA), stated that the Saudi Food and Drug Authority prepared a long term strategy which aims to present an educational programs concerning about the health, food, drug and how to use the medical devices.

In accordance with the continuity of scientific lectures which organized by drug sector and the firms that related to its work, The sector holds a scientific lecture by the name of (the stability of biological products). This has been done within the scientific activity of the drug sector that aims to good preparation and readying to transport some duties.

At the beginning of the ceremony, the vice president for drug affairs Prof. Saleh Abdullah Bawazeer welcomed the honorable attendance and thanks the lecturer Prof. Heuberts Schelekns.

His Excellency prof. Mohammed bin Ahmed Alkanhal, the Acting Executive President of the SFDA, inaugurated the activities of prevention week against poisoning during the 14th to the 20th of Thulqida, 1428H, which equals the 24th to the 30th of November, 2007, in Madareem Crown ( Alfahad Crown formerly). The celebration was introduced by Dr. Abdulmuhsin bin Humaid Alruhaimi, the Director of Researches and Publishing Department, and started  a recitation of Holy Quran verses. Then, prof. Alkanhal announced the emblem of the week .. '' Inattentiveness….

شارك عدد من موظفي قطاع الدواء في فعاليات أسبوع الوقاية من التسمم الدوائي وذلك بهدف توعية المجتمع ضد أخطار التسمم الدوائي وما ينجم عن ذلك من تبعات سيئة لاتحمد عقباها، وقد استعانوا بالإحصاءات والبراهين التي تبين حجم هذه المشكلة على أفراد المجتمع السعودي، وبخاصة صغار السن ممن هم دون السادسة. وذلك بإشراف مباشر من مدير إدارة الأبحاث والنشر الدكتور عبدالمحسن الرحيمي.

On January 8, 2008, the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom's equivalent to the Saudi Food and Drug Authority (SFDA), issued an advise for Statin users in the latest issue of Drug Safety Update newsletter.

On January 26, 2008, the U.S. Food and Drug Administration (FDA), the American equivalent to the Saudi Food and Drug Authority (SFDA), has issued an early communication about ongoing data review for the following cholesterol-lowering agents:

The Drug Sector at The Saudi Food and Drug Authority (SFDA) along with the corporation program of the International Bank hosted Dr. Thomas Lailouf, the expert of drug laboratories and former director of laboratories at the American Food and Drug Administration (FDA), from the 2nd of February 2008 up to the 7th of February 2008 for the purpose of estimating the current status of laboratories concerning the analysis of pharmaceutical products, establishing the visions and appropriate proposition to develop the pharmaceutical products.

    From 23th , 24^th of February, the Drug Sector holds a training program on the assessment of pharmaceutical products file system(EURS is yours) which has been granted by the sector recently. This system used to estimate the electronic registration files. The vice president for drug affairs, the preparation committee, the manager and the employee of registration department has attended the workshop.

On Monday 24th of March, 2008, The drug sector at the Saudi Food and Drug Authority (SFDA) hosted a lecture about generic drugs. The lecture was presented by Dr. Sultan Ghani, the expert in quality assessment of generic drugs in Health Canada. The title of the lecture was (The Generic Drugs Program in Health Canada). Dr. Ghani showed the experience of Health Canada in the field of evaluation, regulation and registration of drugs.

From the 17th to the 21th of March, 2008, the Saudi Food and Drug Authority (SFDA) participated in a workshop on the regulations of clinical trials which was held in Thailand. The director of the department of research and publication at Drug sector, Dr. Abdulmohsen Al Rohaimi, represented the (SFDA) at this workshop where he presented a lecture about the regulations of clinical trials in the kingdom and the role of (SFDA) in this field.